Craig Smith Email & Phone Number | I am intrigued by the vision of practical innovation. I have always been highly motivated by therapeutic-based research and am drug-oriented in my research interests. The exploration of new therapies and markets is a key interest of mine. I believe I can be valuable to that mission. I am currently available to discuss employment possibilities. I led 2 compounds from the discovery process to the phase 3 level, with several patents and publications. I have been referred to as a drug hunter, and, as such, my outlook is very drug-oriented. While I concede that no one person can be proficient in all things, I do believe in the importance of being vigilant of the tasks at hand. I believe that practical innovation, using already developed drugs, will only enhance chances of success, especially in the present “hard times” for the pharmaceutical history. I hope we can have a more detailed discussion in the future. Selected Accomplishments I initiated the HP184 patent for MS, stroke, spinal cord injury and other neurological diseases of impaired conduction. I was named Project Leader and co-ordinated both internal and external studies to support these claims. This experience has allowed me to interact with Chemical Manufacturing, Drug Safety and Metabolism, Clinical Design and Marketing, for example. I had a pivotal role in the successful out-licensing of another compound for the indication of over-active bladder. I also, using “cold calls”, initiated contact with groups involved with a sustainable taxane formulation, and SLOS treatment. Specialties: General Background I have always been highly motivated by therapeutic-based research and am drug-oriented in my research interests. The exploration of new therapies and markets is a key interest of mine. I have been involved with many compounds that reached IND stage, as well as several that were stopped just prior to that stage. As such, my outlook is very drug-oriented.

Craig Smith

I am intrigued by the vision of practical innovation. I have always been highly motivated by therape...
Hillsborough, New Jersey, United States

*50 free lookup(s) per month.

No credit card required.

Craig Smith’s Email craig.smith@sanofi.com

Craig Smith’s Phone Numbers

Get CRAIG’s Phone Number (For Free)

Social Media

Craig Smith’s Location Hillsborough, New Jersey, United States

Craig Smith’s Current Industry Sanofi Aventis

Craig Smith’s Prior Industry

Not the Craig Smith you were looking for?

Find accurate emails & phone numbers for over 700M professionals.

Work Experience

Sanofi Aventis

research investigator

1979-01-01 00:00:00 - Present

Skills

No Skills Available

Languages

No Languages Available

FAQ About Craig Smith

Craig Smith is located at
Hillsborough, New Jersey, United States

Craig Smith is a I am intrigued by the vision of practical innovation. I have always been highly motivated by therapeutic-based research and am drug-oriented in my research interests. The exploration of new therapies and markets is a key interest of mine. I believe I can be valuable to that mission. I am currently available to discuss employment possibilities. I led 2 compounds from the discovery process to the phase 3 level, with several patents and publications. I have been referred to as a drug hunter, and, as such, my outlook is very drug-oriented. While I concede that no one person can be proficient in all things, I do believe in the importance of being vigilant of the tasks at hand. I believe that practical innovation, using already developed drugs, will only enhance chances of success, especially in the present “hard times” for the pharmaceutical history. I hope we can have a more detailed discussion in the future. Selected Accomplishments I initiated the HP184 patent for MS, stroke, spinal cord injury and other neurological diseases of impaired conduction. I was named Project Leader and co-ordinated both internal and external studies to support these claims. This experience has allowed me to interact with Chemical Manufacturing, Drug Safety and Metabolism, Clinical Design and Marketing, for example. I had a pivotal role in the successful out-licensing of another compound for the indication of over-active bladder. I also, using “cold calls”, initiated contact with groups involved with a sustainable taxane formulation, and SLOS treatment. Specialties: General Background I have always been highly motivated by therapeutic-based research and am drug-oriented in my research interests. The exploration of new therapies and markets is a key interest of mine. I have been involved with many compounds that reached IND stage, as well as several that were stopped just prior to that stage. As such, my outlook is very drug-oriented.